158 related articles for article (PubMed ID: 30689395)
1. Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Caffeine Disposition in Pregnancy.
Darakjian LI; Kaddoumi A
Mol Pharm; 2019 Mar; 16(3):1340-1349. PubMed ID: 30689395
[TBL] [Abstract][Full Text] [Related]
2. A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.
Gaohua L; Abduljalil K; Jamei M; Johnson TN; Rostami-Hodjegan A
Br J Clin Pharmacol; 2012 Nov; 74(5):873-85. PubMed ID: 22725721
[TBL] [Abstract][Full Text] [Related]
3. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
Abduljalil K; Pansari A; Jamei M
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
[TBL] [Abstract][Full Text] [Related]
4. A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women.
Ke AB; Nallani SC; Zhao P; Rostami-Hodjegan A; Isoherranen N; Unadkat JD
Drug Metab Dispos; 2013 Apr; 41(4):801-13. PubMed ID: 23355638
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.
Yu T; Campbell SC; Stockmann C; Tak C; Schoen K; Clark EA; Varner MW; Spigarelli MG; Sherwin CM
J Clin Pharmacol; 2016 May; 56(5):590-6. PubMed ID: 26358647
[TBL] [Abstract][Full Text] [Related]
6. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
[TBL] [Abstract][Full Text] [Related]
7. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A
J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678
[TBL] [Abstract][Full Text] [Related]
8. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
[TBL] [Abstract][Full Text] [Related]
9. Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy.
Pillai VC; Shah M; Rytting E; Nanovskaya TN; Wang X; Clark SM; Ahmed MS; Hankins GDV; Caritis SN; Venkataramanan R
Br J Clin Pharmacol; 2022 Jan; 88(1):271-281. PubMed ID: 34185331
[TBL] [Abstract][Full Text] [Related]
10. Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy.
Alqahtani S; Kaddoumi A
PLoS One; 2015; 10(10):e0139762. PubMed ID: 26431339
[TBL] [Abstract][Full Text] [Related]
11. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G
Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743
[TBL] [Abstract][Full Text] [Related]
12. Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment.
Fendt R; Hofmann U; Schneider ARP; Schaeffeler E; Burghaus R; Yilmaz A; Blank LM; Kerb R; Lippert J; Schlender JF; Schwab M; Kuepfer L
CPT Pharmacometrics Syst Pharmacol; 2021 Jul; 10(7):782-793. PubMed ID: 34053199
[TBL] [Abstract][Full Text] [Related]
13. Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancy.
Chen J; You X; Wu W; Guo G; Lin R; Ke M; Huang P; Lin C
Eur J Pharm Sci; 2023 Feb; 181():106349. PubMed ID: 36496167
[TBL] [Abstract][Full Text] [Related]
14. Rate of caffeine metabolism and risk of spontaneous abortion.
Fenster L; Quale C; Hiatt RA; Wilson M; Windham GC; Benowitz NL
Am J Epidemiol; 1998 Mar; 147(5):503-10. PubMed ID: 9525538
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
16. When special populations intersect with drug-drug interactions: Application of physiologically-based pharmacokinetic modeling in pregnant populations.
Sychterz C; Galetin A; Taskar KS
Biopharm Drug Dispos; 2021 Apr; 42(4):160-177. PubMed ID: 33759451
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification.
Moj D; Britz H; Burhenne J; Stewart CF; Egerer G; Haefeli WE; Lehr T
Cancer Chemother Pharmacol; 2017 Nov; 80(5):1013-1026. PubMed ID: 28988277
[TBL] [Abstract][Full Text] [Related]
18. PBPK/PD Modeling of Nifedipine for Precision Medicine in Pregnant Women: Enhancing Clinical Decision-Making for Optimal Drug Therapy.
Liu X; Wang W; Chen J; Chen D; Tao Y; Ouyang D
Pharm Res; 2024 Jan; 41(1):63-75. PubMed ID: 38049651
[TBL] [Abstract][Full Text] [Related]
19. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.
De Sousa Mendes M; Hirt D; Urien S; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Benaboud S
Br J Clin Pharmacol; 2015 Nov; 80(5):1031-41. PubMed ID: 26011128
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy.
Li J; Zhao H; Song JM; Zhang J; Tang YL; Xin CM
Int J Gynaecol Obstet; 2015 Aug; 130(2):116-22. PubMed ID: 26026343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
